New Delhi, July 20 (IANS) An international team of researchers conducted a mice study that showed that targeting the production of a key inflammatory protein can extend lifespan, and reduce old age-related diseases.
The team from the Medical Research Council Laboratory of Medical Science (MRC LMS), Imperial College London in the UK, and Duke-NUS Medical School in Singapore investigated the effects of inflammatory proteins IL-11 by generating mice with the IL-11 (interleukin 11) gene removed.
This increased the mice’s lifespan by more than 20 per cent on average, revealed the study, published in the journal Nature.
They also gave 75-week-old mice, equivalent to around 55 years in humans, an injection of an anti-IL-11 antibody, a medicine that inhibits the effects of IL-11 in the body.
Mice treated with an anti-IL-11 drug from 75 weeks of age had their median lifespan extended by 22.4 per cent in males and 25 per cent in females, with an average lifespan of 155 weeks compared to 120 weeks in untreated mice.
The treatment reduced cancer deaths, fibrosis, chronic inflammation, and poor metabolism, with minimal side effects.
Professor Stuart Cook highlighted the potential for similar effects in humans, stating, “The treated mice had fewer cancers and were free from the usual signs of ageing and frailty.”
This research, though conducted in mice, opens possibilities for extending healthy ageing in humans.
–IANS
ts/rvt/svn
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
